Mediwound Ltd (MDWD) Stock Analysis

Mediwound Ltd (MDWD) is a publicly traded company in the HEALTHCARE sector. It trades at $13.82, carries a market capitalization of $177.62M. This page summarizes the public market data, fundamentals, and frequently asked questions for MDWD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Mediwound Ltd currently has a Neutral sentiment score of -0.10.

About Mediwound Ltd

MediWound Ltd. is a leading biopharmaceutical company based in Yavne, Israel, dedicated to developing and commercializing innovative biotherapeutic solutions for tissue repair and regeneration. The company’s flagship product, NexoBrid, represents a transformative advance in burn treatment, underscoring its commitment to fulfilling unmet medical needs within the wound care sector. With a strategic focus on pioneering therapies and the potential for significant growth in the dynamically evolvin...

GNG Research Analysis

GNG Research scores Mediwound Ltd (MDWD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MDWD.

Frequently Asked Questions

Does MDWD pay dividends?

Mediwound Ltd (MDWD) does not currently pay a regular dividend.

What is MDWD's market cap?

Mediwound Ltd (MDWD) has a market capitalization of $177.62M with a current stock price of $13.82.